Status:
COMPLETED
AL-15469A for the Treatment of Bacterial Conjunctivitis
Lead Sponsor:
Alcon Research
Conditions:
Bacterial Conjunctivitis
Eligibility:
All Genders
1+ years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.
Eligibility Criteria
Inclusion
- signs and symptoms of bacterial conjunctivitis
- Other protocol-defined inclusion criteria may apply
Exclusion
- under 1 mo. age
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
695 Patients enrolled
Trial Details
Trial ID
NCT00332293
Start Date
May 1 2006
End Date
December 1 2006
Last Update
November 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon for Trial Locations
Fort Worth, Texas, United States, 76134